Barclays has kept a Neutral stance on European insurers, arguing that steady underlying operating performance, benign catastrophe activity and favourable market conditions should help underpin reported earnings as companies report full-year and interim results. Within that framework, the broker identified four names to watch closely into results: Ageas, AXA, MAPFRE and Swiss Re.
Barclays framed its sector view around three supporting factors - consistent operating trends, an unusually quiet catastrophe environment and market conditions that are helping headline earnings - but stopped short of upgrading its overall view on insurers. Instead, it recommended specific positioning within the group of names it believes will show differentiated outcomes when results arrive.
Ageas
Barclays reiterated an "overweight" rating on Ageas and increased its price target to 073 from 066.5. The broker also raised its 2026-2028 estimates by about 5% on average. Barclays expects higher cash remittances to be a driver for shareholder returns in 2026, and it forecasts first-half net operating profit of 0757 million. That profit projection reflects several company-specific items cited by the broker: consolidation of AG in Belgium, full integration of esure and Saga in Europe, stronger life capital gains and materially higher dividends from China.
Those positives, Barclays notes, should be partly offset by weather-related claims. The broker also expects the solvency ratio to decline to 197% from around 211% at end-2025, with the fall attributed to a set of discrete effects: the Taiping Pension closure, debt grandfathering, a Belgium downgrade and mark-to-market movements.
AXA
Barclays kept its "overweight" recommendation on AXA and kept a 047.5 price target, arguing that AXA trades at an undemanding valuation relative to consensus expectations and could rerate. The broker highlighted AXA e2 80 99s higher weighting to property-and-casualty (P&C) business and a clear capital management policy as factors that should help its market-implied cost of equity align more closely with peers over time.
Barclays' base-case forecast assumes underlying post-tax earnings rise to 08.9 billion in 2026 from 08.4 billion in 2025, with P&C underlying earnings increasing to 06.3 billion. The broker sets out a conditional view: there is upside to its scenario if loss ratios improve and downside risk if P&C profitability weakens.
MAPFRE
For MAPFRE Barclays retained an "equal weight" rating and a 03.78 price target. The broker cautioned that a softer gross written premium trajectory could make MAPFRE e2 80 99s growth targets difficult to achieve. Barclays expects motor insurance margins in Iberia to improve as price increases accelerate and profitability recovers, but judged that MAPFRE's portfolio of businesses does not generate sufficiently high return on equity to offset operational and currency risks across multiple jurisdictions. As a consequence, Barclays sees limited upside to its target price.
Swiss Re
Barclays retained an "underweight" rating on Swiss Re and nudged its price target up to 116 Swiss francs from 113 francs. The broker warned that accelerating blended reinsurance price declines at the July 1 renewals represent a potential disappointment for investors. At the same time, Barclays expects reinsurers to benefit from a benign catastrophe backdrop, noting first-half large losses were 40%-50% below historical averages. However, the broker believes major European reinsurers are more likely to use the resulting earnings tailwind to build reserve buffers rather than to lift capital returns.
Overall, Barclays' approach combines a neutral sector stance with selective convictions: overweight positions where it sees clearer capital or earnings upsides, neutral where growth and returns look constrained, and underweight where renewal pricing and reinsurance dynamics could weigh on near-term performance.